Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Eni ADR	E	30. oct 2024	30.27	+0.46
Enlight Renewable Energy	ENLT	30. oct 2024	16.02	-0.68
Enlink Midstream LLC Unit	ENLC	30. oct 2024	14.90	+0.40
Enliven Therapeutics	ELVN	30. oct 2024	28.39	-0.46
Enlivex Therapeutics	ENLV	30. oct 2024	1.38	-3.50
Ennis	EBF	30. oct 2024	20.43	-0.87
Enova International	ENVA	30. oct 2024	88.12	+1.16
Enovis	ENOV	30. oct 2024	42.06	+3.83
Enovix	ENVX	30. oct 2024	10.48	-1.41
Enphase Energy	ENPH	30. oct 2024	82.47	-0.72
Enphys Acquisition	NFYS	30. oct 2024	10.99	0.00
Enpro	NPO	30. oct 2024	147.99	-0.87
Enservco	ENSV	30. oct 2024	0.15	+3.73
Enstar Group	ESGR	30. oct 2024	325.01	-0.11
Enstar Group Depository E Pref	ESGRO	30. oct 2024	21.30	+3.45
Enstar Pref	ESGRP	30. oct 2024	21.17	0.00
Ensysce Biosciences	ENSC	30. oct 2024	0.64	+53.81
Entegris	ENTG	30. oct 2024	106.91	-1.66
Entera Bio	ENTX	30. oct 2024	1.86	-1.59
Entergy	ETR	30. oct 2024	134.40	+0.20
Entergy Texas A Pref	ETI-	30. oct 2024	24.38	+0.54
Entergy Utility Enterprises	EMP	30. oct 2024	22.76	-0.09
Entero Therapeutics	ENTO	30. oct 2024	0.61	+1.63
Enterprise Bancorp	EBTC	30. oct 2024	32.13	-1.17
Enterprise Financial Services	EFSC	30. oct 2024	53.79	+1.62
Enterprise Financial Services A Pref	EFSCP	30. oct 2024	20.64	+0.29
Enterprise Products Partners LP Unit	EPD	30. oct 2024	29.26	+0.55
Entrada Therapeutics	TRDA	30. oct 2024	17.23	-0.29
Entravision Communications	EVC	30. oct 2024	2.31	+0.87
Envela	ELA	30. oct 2024	5.29	-1.31

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.